The agency said Jeremy Perrott violated the agency's code of conduct.
New report reveals large amount of opioids shipped to Missouri; Humana partners with Walgreens; Wyden requests details on Trump-Pfizer agreement
If you were unfamiliar with MediaMonks and want to know more about the company that Martin Sorrell has made his first capture, read on.
Tham Khai Meng has been with Ogilvy since 1999.
He's a veteran of Deep Focus, Wunderman, and ATTIK.
The government agency released its latest guidance this week.
Some Twitter accounts could lose millions of followers when the social platform purges large numbers of "locked" accounts this week.
Pfizer announces restructuring hours after about face on price hikes; Feds to slash funding for ACA "navigators"; Study finds rural states lag in combating heart disease.
In an interview with Campaign, Sir Martin Sorrell insisted his new company, S4 Capital, is listening to clients because they are "questioning" how agencies are delivering work.
Sir Martin Sorrell's S4 Capital has agreed to buy Dutch content business MediaMonks in a deal that is strikingly different from how he structured acquisitions at WPP.
Directing its reps to call on GPs with little to no opioid experience, Purdue introduced aggressive promotional tactics into the prescription opioid marketing playbook.
Biogen's recently soaring stock price can be attributed to investor optimism in one of the most stubborn areas of drug development.
CMS ends plan to make Novartis cancer treatment cheaper; Trump calls out Pfizer on Twitter for price hikes; News organizations sue to get federal opioid data.
The most comprehensive look at the pharma and healthcare agency world from MM&M.
The deals follow last year's additions of Cambridge BioMarketing and MicroMass Communications.
Positive Alzheimer's trial sends Biogen shares surging; A year after crisis, analysts come around to AstraZeneca stock; Ironwood cuts 40 jobs ahead of split.
Amazon integration with PillPack could happen quickly; White House names DEA chief; Purdue stops marketing opioids in Canada.
11 questions for the GW CEO on the watershed moment.
WPP is also bidding for Dutch agency MediaMonks, pitting the group against its former chief executive, Martin Sorrell.
She is taking on the role alongside her role leading FCB Health medical communications subsidiary ProHealth.
UDG Healthcare makes two acquisitions; Lundbeck names Dunsire CEO; Accuracy of DTC genetic tests questioned.
Data marketing firm will become part of IPG Mediabrands portfolio.
The Office of Prescription Drug Promotion has sent its second warning letter of the year.
Fans hailed Disney's response following a strobe-light slip-up in the film Incredibles 2, but a patient group says it must go a step further as it seeks to recover from the blunder.
U.S. hospitals face staple drug shortage; Pfizer hikes price of 100 products; Federal judge blocks Kentucky work-requirement-for-Medicaid plan.
A survey from DRG Digital measured patient and doctor support for Amazon becoming an online pharmacy.
Fosamax appeal goes to Supreme Court; Gottlieb weighs in on Amazon-PillPack deal; Senator demands PhRMA, BIO address sexual harassment.
The campaign is appearing in millennial- and women-focused outlets such as Refinery29, Instagram, Bravo!, HGTV, and Cosmopolitan.
Amazon to acquire PillPack; Babylon Health says its AI diagnoses better than humans; Lilly's arthritis drug sees positive results.
The caregiver's journey is a highly personal one. A study examined their role in treatment decisions
Caregivers are intimately involved in patient health, and that includes deciding on treatments, a new study suggests.
Across the political spectrum, most Americans favor President Donald Trump's proposal to show drug prices in advertisements.
The lawyer for former spokesperson Phoebe Jonas said Bayer created "a big headache for everyone."
The partnerships came about after the Multiple Myeloma Research Foundation and Kantar Health conducted a study on cancer patients' knowledge gaps.
FDA gives priority review to new type of flu treatment; Lynparza shows positive trial data; Nurse practitioner lobby launches national campaign.
The approval answers one question but raises others.
Sir Martin Sorrell regrets not simplifying WPP faster in terms of client-focused work, more country management and making sure this it is underpinned by digital.
Unilever's diversity and inclusion chief Aline Santos has criticized the industry for a lack of action but welcomed the accountability that has come with a spotlight being shone on the issues.
Public trust in the pharma industry has taken a dip, according to recent data. Do actual patients agree?
Wendy Blackburn, EVP of marketing and communications, described the new structure as "a natural evolution of everything we've been doing."
How Atul Gawande caught Warren Buffett's eye; Positive news for Roche's Tecentriq in trial; New York State officials argue Orkambi not worth the cost.
Cannes judges on why one campaign just missed the top Pharma Lions prize.
Unilever is trialing a new agency model which will see creative agency talent within a holding group integrated into a single team.
Opioid supply levels drop; Azar criticized for attending college reunion during border crisis; CVS CEO confident about Aetna deal.
The goal of the product is to educate MS patients about the effect the disease has on cognition.
GoodRx in sales talks; Heron receives breakthrough therapy designation for pain treatment; Novo's diabetes pill proves effective in clinical trials.
Recent healthcare trends, including a physician shortage and the rise of value-based care centers, have put NPs and PAs on the fast track to recruiter popularity. Marketers, take note.
Dr. Atul Gawande named CEO of Amazon, J.P. Morgan, Berkshire Hathaway healthcare venture; Facebook tries to curb illegal opioid sales; More sales layoffs at Purdue Pharma.
New advertising will account for a $24 billion investment this year.
As the Cannes CMO Growth Council meets, marketers weigh in on what they're looking to gain from the Festival and this year's changes.
Kardashian's previous posts for Duchesnay's morning sickness treatments were slammed by the FDA for not including side effects or risk information.
White House to roll out Affordable Care Act rule change; CVS Health teams up with Postal Service; Roche to buy rest of Foundation Medicine.
The Federal Bureau of Investigation is looking into media trading and transparency in the US advertising market.
Judges awarded the category's top prize to New York's John X. Hannes on behalf of Montefiore. They also handed out eight Gold Lions.
Since the inception of the award in 2014, the pharma Grand Prix has only been awarded twice.
Here are the Lions Health winners in the pharma category.
Here are the Lions Health winners in the health and wellness category.
WPP's Read: We're focusing on collaboration, rather than 'collapsing' agency brands and restructuring
Mark Read has warned against "collapsing" too many WPP agency brands and said driving greater collaboration is more important than a "major restructuring".
This year's Cannes Lions Festival will be different to any that preceded it - but then, it was always thus.
Quest Analytics buys BetterDoctor; Analyst Eric Schmidt to join Allogene Therapeutics; Two-thirds of Americans "very concerned" about cost of health insurance.
It's still entirely up to drugmakers whether they want to make their products available on an experimental basis. Patients may not see it that way.
FCB Health features heavily in a rising percentage of U.S. campaigns that made it to the Pharma Lions shortlist - the company's Rich Levy is jury president this year.
Collete Douaihy, Digitas Health's executive vice president, executive creative director shares advice for navigating Cannes, her opinion on the new schedule, and how she's handling judging.
Eli Lilly CEO says changes needed in drug pricing system; Kentucky sues Walgreens over opioid epidemic; Teva faces migraine drug setback.
The number of entries to Cannes Lions has dropped by 21.4% from last year, which organisers ascribed partly to Publicis Groupe's temporary withdrawal and partly to their decision to restructure the awards programme.
Rishi Shah stepped down from the chief executive position five months ago amid fraud allegations.
Two FDA guidance documents aim to help pharma companies show the value of their drugs to payers beyond what's included in FDA labeling.
BIO afterparty again sparks controversy; GSK meets goal for two-drug HIV treatment; Mylan receives complete response letter for Advair generic.
In the week that former WPP chief Sir Martin Sorrell faced claims of bullying behaviour and paying for a prostitute, the ad group will be breathing a sigh of relief after an AGM that avoided a showdown.
The WPP agency is hoping its reorganization results in more collaboration among health and wellness staffers.
Drugmakers not dropping prices on Trump timeline; Azar backs insurance for those with preexisting conditions; Stryker denies interest in Boston Scientific takeover.
WPP faced tough questions about Sir Martin Sorrell's exit at its annual general meeting, with more than a quarter of WPP shareholders voting against his entitlement to a possible $26.7 million pay-off.
For the first time, the nonprofit is trying to eliminate bans on gay and bisexual men donating blood in countries other than the U.S.
WPP joint COO Mark Read has emailed all staff at the group to tell them to expect respect from their colleagues and announce a group-wide code of conduct review.
FDA puts Sage depression treatment on accelerated timeline; AstraZeneca, Lilly cease Alzheimer's treatment trial; Stryker makes offer for Boston Scientific.
Martin Sorrell's reputation is under increasing fire from the press, with both the 'Financial Times' and the 'Daily Mail' using their front pages to air allegations about his conduct today.
Eckert returns to lead Sprout Pharmaceuticals; Sorrell denies prostitution allegation; AHIP warns about removing key Obamacare provisions.
WPP's unpublished investigation into its former chief executive Martin Sorrell's conduct examined whether he used company funds to pay a prostitute, according to reports.
The creative director of Sudler Australia shares her opinion on changes to Cannes' scheduling and how she's preparing for long days spent judging.
WPP investors are set to lodge a significant protest over Sir Martin Sorrell's pay-off but executive chairman Roberto Quarta is expected to survive.
Novo Nordisk considers cutting 3,000 jobs; Pharma companies pressured to move birth control over the counter; Gates Foundation launches a nonprofit biotech.
Former JWT global chief executive Gustavo Martinez has departed WPP in a sign that the ad group's new leadership wants to draw a line under his controversial tenure.
Women healthcare leaders discussed the gender pay gap and tools for women to advocate for themselves on stage at MM&M's Hall of Femme event Thursday.
Life and career lessons from Novartis' Vanessa Thirion-Cullity and other executives.
The State of Diversity in Healthcare Marketing: For years, pharma has talked about diversity and inclusion issues in its midst, with some pundits saying the industry was slow to embrace diversity and others claiming that it's ahead of the curve.
Bayer closes Monsanto deal after lengthy antitrust review; Bezos, Dimon, Buffett pick CEO to run healthcare venture; Novartis to avoid criminal actions over Cohen payments.
Pillo's voice-activated robot will be studied among those 50-plus with diabetes. The robot uses facial recognition and can respond HIPAA-compliantly to questions.
The CEO of Ogilvy CommonHealth North America shares advice for first-time attendees at Cannes.
Athenahealth CEO steps down; Former Celgene chief executive wins New Jersey Senate primary; Big Pharma not planning campaign against Trump drug pricing plan.
Investor pressure is likely to force WPP into selling Kantar, possibly along with other assets - which could open opportunities for Sir Martin Sorrell's new vehicle S4 Capital.
Just after the launch of Marcel, Publicis chief executive Arthur Sadoun was bombarded with questions from a packed room of clients, staff, and journalists.
AstraZeneca VP, head of U.S. oncology, Olivier Nataf details how being a company lifer impacted his career.
Two touted products in the pipeline reflect three of medical marketing's most profound modern-era challenges.
Medical science liaisons are essential participants in most aspects of the commercialization process.
Medicare Part D brand-name drug costs up even as prescriptions fall; Gottlieb could speed up approval process for competitors of first-to-market drugs; FDA approves Filphila.
Ogilvy is ditching Mather, introducing a new corporate identity and cementing months of streamlining with a simplified organizational structure that chief executive John Siefert says will "build a new model for our industry".
Meet "the connectors" as four of the best-regarded medical science liaisons and the leader of the MSL Society discuss what they do, how they do it, and why their work is so vital.
MM&M asked the pharma marketing community at large, via social media and other efforts, to provide its POV on equality, diversity, and inclusion.
Mark Stenhouse, president of Cologuard at Exact Sciences, shares his wake up routine and how he manages a busy schedule.
Although analysts predict this dynamic won't last long.
New study finds early-stage breast cancer may not need chemo; Merck's Keytruda succeeds in more studies; Athenahealth CEO faces allegations of inappropriate behavior